SPAR PHARMA LLP

Overview

SPAR PHARMA LLP is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering (±)-4-FLUORO-A.-(2-METHYL-1-OXOPROPYL)- Y-OXO-N, ß - DIPHENYL BENZENE BUTANEAMIDE (DKT).

API / Drug Master Files

SPAR PHARMA LLP holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• (±)-4-FLUORO-A.-(2-METHYL-1-OXOPROPYL)- Y-OXO-N, ß - DIPHENYL BENZENE BUTANEAMIDE (DKT)Active2024-07-17

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to SPAR PHARMA LLP in our records. PharmaTek screens the full directory against live FDA enforcement data.